• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔内阻抗的变化与急性失代偿性心力衰竭住院风险的后续变化相关:无需患者警报的植入式设备监测的临床实用性。

Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.

机构信息

Lancaster Heart and Stroke Foundation, Lancaster, Pennsylvania, USA.

出版信息

J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012. Epub 2009 Mar 17.

DOI:10.1016/j.cardfail.2009.01.012
PMID:19643357
Abstract

BACKGROUND

Acute decreases in intrathoracic impedance monitoring have been shown to precede heart failure hospitalization in a limited population of heart failure patients. We evaluated the relationship between changes in intrathoracic impedance with hospitalizations associated with acute decompensated heart failure (ADHF) in patients with cardiac resynchronization therapy plus defibrillator (CRT-D) devices.

METHODS AND RESULTS

The study enrolled 326 heart failure patients who had received CRT-D with impedance-monitoring capabilities (InSync Sentry, Medtronic). The date and duration of ADHF hospitalizations were retrospectively identified before device interrogation to obtain device diagnostic information. During 333 +/- 96 days of device monitoring, 228 patients experienced 540 intrathoracic impedance fluid index threshold crossings events (TCE) at the nominal threshold value (60 Omega. days). During the initial 4-month evaluation period, 17 subjects experienced 22 ADHF hospitalizations. In the subsequent monitoring period (206 +/- 95 days), 18 patients experienced 24 hospitalizations. The occurrence of TCEs during the monitoring period was independently correlated with the subsequent rate of ADHF hospitalization such that each TCE event during the risk stratification period was associated with a 35% increased risk for ADHF hospitalization in the remaining study period (P = .001). Poisson regression indicated that the subgroup of patients with an annual average rate of more than 3 threshold crossings per year during the monitoring period were significantly more likely to be hospitalized for ADHF than those patients with no TCE during the monitoring period (0.76 [0.20-1.325] vs. 0.14 [0.05-0.23] hospitalizations/subject/y [95%CI]; P = .02). Likewise, Kaplan-Meier analysis revealed that subsets of patients with more than 3 TCEs per year or with more than 30 days per year above threshold during the risk stratification period had significantly higher rates of ADHF hospitalization during the post risk stratification period than subjects with no TCE events, respectively.

CONCLUSIONS

In this multicenter retrospective cohort study, serial decreases in intrathoracic impedance sufficient to generate a fluid index threshold crossing as well as the net duration that the index remained above threshold during a 4-month monitoring period were associated with subsequent risk of ADHF hospitalization.

摘要

背景

在有限的心力衰竭患者群体中,已经证明胸腔内阻抗监测的急性下降先于心力衰竭住院。我们评估了与心脏再同步治疗除颤器 (CRT-D) 装置相关的急性失代偿性心力衰竭 (ADHF) 住院患者的胸腔内阻抗变化之间的关系。

方法和结果

该研究纳入了 326 名接受过 CRT-D 且具有阻抗监测功能的心力衰竭患者(InSync Sentry,美敦力)。在进行设备检测之前,回顾性地确定 ADHF 住院的日期和持续时间,以获取设备诊断信息。在 333±96 天的设备监测期间,228 名患者在名义阈值(60Ω.天)处经历了 540 次胸腔内阻抗液体指数阈值穿越事件(TCE)。在最初的 4 个月评估期间,17 名患者经历了 22 次 ADHF 住院。在随后的监测期间(206±95 天),18 名患者经历了 24 次住院。监测期间 TCE 的发生与随后的 ADHF 住院率独立相关,以至于风险分层期间的每次 TCE 事件都与剩余研究期间 ADHF 住院风险增加 35%相关(P=0.001)。泊松回归表明,在监测期间每年平均超过 3 次阈值穿越率的亚组患者比在监测期间没有 TCE 的患者更有可能因 ADHF 住院(0.76[0.20-1.325]与 0.14[0.05-0.23]住院/患者/年[95%CI];P=0.02)。同样,Kaplan-Meier 分析表明,在风险分层期间每年 TCE 超过 3 次或每年超过 30 天超过阈值的亚组患者在风险分层后期间的 ADHF 住院率明显高于无 TCE 事件的患者。

结论

在这项多中心回顾性队列研究中,连续胸腔内阻抗下降足以产生液体指数阈值穿越,以及在 4 个月监测期间该指数保持在阈值以上的净时间与随后的 ADHF 住院风险相关。

相似文献

1
Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.胸腔内阻抗的变化与急性失代偿性心力衰竭住院风险的后续变化相关:无需患者警报的植入式设备监测的临床实用性。
J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012. Epub 2009 Mar 17.
2
Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.通过植入式设备监测胸腔内阻抗检测心力衰竭患者液体蓄积的改良算法。
J Card Fail. 2011 Jul;17(7):569-76. doi: 10.1016/j.cardfail.2011.03.002. Epub 2011 Apr 22.
3
Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.心脏衰竭装置联合诊断可识别出后续有更高心力衰竭住院风险的患者:来自 PARTNERS HF(心力衰竭患者趋势信息获取、评估和症状相关性研究计划)研究的结果。
J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10. doi: 10.1016/j.jacc.2009.11.089.
4
Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.胸腔内阻抗监测对植入装置的慢性心力衰竭患者病情恶化发出警报的临床效用。
Eur Heart J. 2007 Aug;28(15):1835-40. doi: 10.1093/eurheartj/ehl506. Epub 2007 Feb 19.
5
Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.心力衰竭患者的胸腔内阻抗监测:与液体状态的相关性及住院前早期预警的可行性
Circulation. 2005 Aug 9;112(6):841-8. doi: 10.1161/CIRCULATIONAHA.104.492207. Epub 2005 Aug 1.
6
Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.对心力衰竭患者进行胸腔内阻抗和右心室压力的连续监测。
Circ Heart Fail. 2010 May;3(3):370-7. doi: 10.1161/CIRCHEARTFAILURE.109.867549. Epub 2010 Mar 2.
7
Device monitoring of intrathoracic impedance: clinical observations from a patient registry.胸腔内阻抗的设备监测:来自患者登记处的临床观察
Am J Cardiol. 2007 May 21;99(10A):23G-8G. doi: 10.1016/j.amjcard.2007.02.039. Epub 2007 Mar 9.
8
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.胸腔内阻抗监测、可听患者警报与心力衰竭患者的结局。
Circulation. 2011 Oct 18;124(16):1719-26. doi: 10.1161/CIRCULATIONAHA.111.043042. Epub 2011 Sep 19.
9
Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.使用植入式除颤器监测胸内阻抗可减少心力衰竭患者的住院次数。
Pacing Clin Electrophysiol. 2009 Mar;32(3):363-70. doi: 10.1111/j.1540-8159.2008.02245.x.
10
Uncovering interim clinical events at the time of clinical encounter by reviewing intrathoracic impedance threshold crossings.通过回顾胸腔内阻抗阈值穿越来发现临床就诊时的临时临床事件。
J Card Fail. 2011 Nov;17(11):893-8. doi: 10.1016/j.cardfail.2011.07.005.

引用本文的文献

1
Application of Telemedicine in the Management of Cardiovascular Diseases: A Focus on Heart Failure.远程医疗在心血管疾病管理中的应用:聚焦心力衰竭
Rev Cardiovasc Med. 2025 Jul 1;26(6):37835. doi: 10.31083/RCM37835. eCollection 2025 Jun.
2
Remote Monitoring of Cardiac Implantable Electronic Devices in Very Elderly Patients: Advantages and Specific Problems.老年患者心脏植入式电子设备的远程监测:优势与特殊问题
J Cardiovasc Dev Dis. 2024 Jul 3;11(7):209. doi: 10.3390/jcdd11070209.
3
Cardiovascular Implantable Electronic Devices Enabled Remote Heart Failure Monitoring; What We Have Learned and Where to Go Next.
心血管植入式电子设备实现远程心力衰竭监测:我们学到了什么以及下一步何去何从。
J Cardiovasc Dev Dis. 2023 Mar 31;10(4):152. doi: 10.3390/jcdd10040152.
4
Remotely Monitored Cardiac Implantable Electronic Device Data Predict All-Cause and Cardiovascular Unplanned Hospitalization.远程监测心脏植入式电子设备数据可预测全因和心血管非计划性住院。
J Am Heart Assoc. 2022 Aug 16;11(16):e024526. doi: 10.1161/JAHA.121.024526. Epub 2022 Aug 9.
5
Electronic Health Records and Heart Failure.电子健康记录与心力衰竭
Heart Fail Clin. 2022 Apr;18(2):201-211. doi: 10.1016/j.hfc.2021.12.004. Epub 2022 Mar 4.
6
A reproducible sensor pattern to suspect COVID19 pulmonary infection with LATITUDE. Case report and literature review.利用 LATITUDE 对疑似 COVID19 肺部感染的可重现传感器模式:病例报告及文献复习。
Pacing Clin Electrophysiol. 2022 Mar;45(3):425-430. doi: 10.1111/pace.14469. Epub 2022 Feb 23.
7
Impact of Remote Monitoring on Hospitalizations for Heart Failure: A Five-year Single-center Experience.远程监测对心力衰竭住院治疗的影响:一项为期五年的单中心经验
J Innov Card Rhythm Manag. 2021 Aug 15;12(8):4621-4624. doi: 10.19102/icrm.2021.120802. eCollection 2021 Aug.
8
Remote monitoring and telemedicine in heart failure: implementation and benefits.心力衰竭的远程监测与远程医疗:实施与益处
Curr Cardiol Rep. 2021 May 7;23(6):55. doi: 10.1007/s11886-021-01487-2.
9
Beyond the stethoscope: managing ambulatory heart failure during the COVID-19 pandemic.听诊器之外:在 COVID-19 大流行期间管理门诊心力衰竭。
ESC Heart Fail. 2021 Apr;8(2):999-1006. doi: 10.1002/ehf2.13201. Epub 2021 Jan 27.
10
Remotely monitored inactivity due to COVID-19 lockdowns. Potential hazard for heart failure patients.因新冠疫情封锁导致的远程监测到的身体活动不足。对心力衰竭患者的潜在危害。
Saudi Med J. 2020 Nov;41(11):1211-1216. doi: 10.15537/smj.2020.11.25449.